Home
TCRX
TCRX News

Latest TScan Therapeutics Inc. (TCRX) News on July 27, 2024

TScan Therapeutics Decline Means Insider Profits Down To US$54k

Simply Wall St.

a month ago

TScan Therapeutics Decline Means Insider Profits Down To US$54k

Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?

MT Newswires

a month ago

TScan Therapeutics Names Stephen Biggar Board Chair

TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire

a month ago

TScan Therapeutics Announces Updates to its Board of Directors

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

2 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

2 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

MT Newswires

2 months ago

TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

GlobeNewswire

2 months ago

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

Zacks

2 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

MT Newswires

2 months ago

Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

GlobeNewswire

3 months ago

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

3 months ago

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

3 months ago

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

GlobeNewswire

3 months ago

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire

3 months ago

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

GlobeNewswire

3 months ago

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

TScan Therapeutics Announces Closing of Upsized Public Offering

GlobeNewswire

3 months ago

TScan Therapeutics Announces Closing of Upsized Public Offering

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

GlobeNewswire

3 months ago

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

GlobeNewswire

3 months ago

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

GlobeNewswire

3 months ago

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

GlobeNewswire

4 months ago

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%

Simply Wall St.

4 months ago

Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%

TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline

GuruFocus.com

5 months ago

TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

5 months ago

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

5 months ago

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?

Zacks

5 months ago

TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

5 months ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

GlobeNewswire

6 months ago

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

Associated Press Finance

6 months ago

Clearfield: Fiscal Q1 Earnings Snapshot

Clearfield Reports Fiscal First Quarter 2024 Results

GlobeNewswire

6 months ago

Clearfield Reports Fiscal First Quarter 2024 Results

Reuters

6 months ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

6 months ago

A Massive Problem With Apple Stock Today

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

GlobeNewswire

6 months ago

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

GlobeNewswire

6 months ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

NVE Corp's Dividend Analysis

GuruFocus.com

6 months ago

NVE Corp's Dividend Analysis

ACNB Corporation Announces First Quarter Cash Dividend

GlobeNewswire

6 months ago

ACNB Corporation Announces First Quarter Cash Dividend

With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot at stake

Simply Wall St.

6 months ago

With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot at stake

Reuters

6 months ago

UPDATE 4-Atomic bomb blockbuster 'Oppenheimer' leads Oscar nominations

Associated Press Finance

6 months ago

RBB: Q4 Earnings Snapshot

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

Business Wire

6 months ago

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

Business Wire

6 months ago

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

loanDepot begins bringing more systems back online after cyberattack

HousingWire

6 months ago

loanDepot begins bringing more systems back online after cyberattack

5 Outstanding Small Cap Value Stocks

Zacks

6 months ago

5 Outstanding Small Cap Value Stocks

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

6 months ago

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

3 Pot Stocks to Avoid Like the Plague in 2024

Motley Fool

6 months ago

3 Pot Stocks to Avoid Like the Plague in 2024

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

Zacks

6 months ago

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

Business Wire

6 months ago

Bridge Investment Group Announces Key 2024 Promotions

Oppenheimer Names Elizabeth Coolidge Head of Public Finance

PR Newswire

6 months ago

Oppenheimer Names Elizabeth Coolidge Head of Public Finance

Tims China Partners with Shanghai Metro to Open Tims Coffee Shops in “Line 14” Stations

GlobeNewswire

6 months ago

Tims China Partners with Shanghai Metro to Open Tims Coffee Shops in “Line 14” Stations

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

6 months ago

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

Motley Fool

7 months ago

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

Reuters

7 months ago

UPDATE 5-'Oppenheimer' triumphs at Golden Globes as Hollywood parties again

TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

GlobeNewswire

7 months ago

TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

Should You Think About Buying DocGo Inc. (NASDAQ:DCGO) Now?

Simply Wall St.

7 months ago

Should You Think About Buying DocGo Inc. (NASDAQ:DCGO) Now?

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

Simply Wall St.

7 months ago

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

GlobeNewswire

7 months ago

West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results

GuruFocus.com

7 months ago

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results

Shareholders in Funko (NASDAQ:FNKO) are in the red if they invested five years ago

Simply Wall St.

7 months ago

Shareholders in Funko (NASDAQ:FNKO) are in the red if they invested five years ago

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX

Business Wire

7 months ago

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX

Institutional owners may consider drastic measures as GrafTech International Ltd.'s (NYSE:EAF) recent US$100m drop adds to long-term losses

Simply Wall St.

7 months ago

Institutional owners may consider drastic measures as GrafTech International Ltd.'s (NYSE:EAF) recent US$100m drop adds to long-term losses

Seacoast Banking (SBCF) Moves 5.1% Higher: Will This Strength Last?

Zacks

7 months ago

Seacoast Banking (SBCF) Moves 5.1% Higher: Will This Strength Last?

GrafTech Announces Increased Public Float through Consortium Stock Distribution and Board Resignation

Business Wire

7 months ago

GrafTech Announces Increased Public Float through Consortium Stock Distribution and Board Resignation

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire

8 months ago

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

‘Oppenheimer’ to be released in Japan after delay following ‘Barbenheimer’ controversy

CNN Business

8 months ago

‘Oppenheimer’ to be released in Japan after delay following ‘Barbenheimer’ controversy

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

GlobeNewswire

8 months ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

Reuters

8 months ago

'Oppenheimer' to screen in Japan next year after nuclear controversy

Wikipedia releases its top 25 most-viewed pages of 2023

CNN Business

8 months ago

Wikipedia releases its top 25 most-viewed pages of 2023

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why

Zacks

8 months ago

Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why

TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition

GlobeNewswire

8 months ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition

Should Value Investors Buy First Bank (FRBA) Stock?

Zacks

8 months ago

Should Value Investors Buy First Bank (FRBA) Stock?

Thomson Reuters StreetEvents

8 months ago

Q3 2024 Movado Group Inc Earnings Call

Movado Group Inc (MOV) Adjusts Fiscal 2024 Outlook Amid Challenging Retail Environment

GuruFocus.com

8 months ago

Movado Group Inc (MOV) Adjusts Fiscal 2024 Outlook Amid Challenging Retail Environment

Affinius, Clarion Originate $158M Refi for Salt Lake City Multifamily Development

Commercial Observer

8 months ago

Affinius, Clarion Originate $158M Refi for Salt Lake City Multifamily Development

SIT Investment Associates Inc Adds DWS Municipal Income Trust to Its Portfolio

GuruFocus.com

8 months ago

SIT Investment Associates Inc Adds DWS Municipal Income Trust to Its Portfolio

Sotherly Hotels Inc. (NASDAQ:SOHO) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Sotherly Hotels Inc. (NASDAQ:SOHO) Q3 2023 Earnings Call Transcript

Betterware de Mexico Announces Leadership Changes to Support Growth in Jafra

PR Newswire

9 months ago

Betterware de Mexico Announces Leadership Changes to Support Growth in Jafra

Park-Ohio Holdings Corp. (NASDAQ:PKOH) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Park-Ohio Holdings Corp. (NASDAQ:PKOH) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Anika Therapeutics Inc Earnings Call

Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance

GuruFocus.com

9 months ago

Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance

Betterware Reports Third Quarter Increase in Profit Margin

Exec Edge

9 months ago

Betterware Reports Third Quarter Increase in Profit Margin

Share on Social Networks: